Comparative Pharmacology
Head-to-head clinical analysis: METHADOSE versus PHERAZINE W CODEINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADOSE versus PHERAZINE W CODEINE.
METHADOSE vs PHERAZINE W/ CODEINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
Promethazine is a phenothiazine derivative that acts as a histamine H1 receptor antagonist, antiemetic, and sedative. It also exerts anticholinergic and antidopaminergic effects, particularly at D2 receptors. Codeine is an opioid agonist primarily at mu-opioid receptors, leading to analgesia and antitussive effects. The combination enhances sedation and antiemetic action.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
One tablet (promethazine 6.25 mg / codeine 10 mg) orally every 4-6 hours as needed; maximum 4 tablets in 24 hours.
None Documented
None Documented
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Promethazine: 9-16 hours in adults; codeine: 2.5-3.5 hours; morphine: 1.5-2 hours. Clinical context: The half-life of codeine is shorter, but its active metabolite morphine contributes to analgesia. Accumulation may occur with repeated dosing.
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Renal (50-70% as unchanged promethazine and metabolites; codeine and its metabolites, primarily morphine and codeine-6-glucuronide, are excreted renally). Biliary/fecal elimination accounts for less than 10%.
Category C
Category D/X
Opioid Agonist
Opioid Agonist